Zobrazeno 1 - 10
of 348
pro vyhledávání: '"Trebeden-Negre H"'
Autor:
Desvaux E; Institut de recherches internationales Servier, 92150 Suresnes, France., Moingeon P; Institut de recherches internationales Servier, 92150 Suresnes, France., Bril A; Institut de recherches internationales Servier, 92150 Suresnes, France., Trebeden-Negre H; Institut de recherches internationales Servier, 92150 Suresnes, France.
Publikováno v:
Medecine sciences : M/S [Med Sci (Paris)] 2022 Apr; Vol. 38 (4), pp. 337-339. Date of Electronic Publication: 2022 Apr 29.
Autor:
Ahmed, Eman N.1,2 (AUTHOR) lauren.cutmore@nih.gov, Cutmore, Lauren C.1 (AUTHOR), Marshall, John F.1 (AUTHOR) j.f.marshall@qmul.ac.uk
Publikováno v:
Cancers. Sep2024, Vol. 16 Issue 18, p3186. 21p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brendel C; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA., Negre O; bluebird bio, Inc., Cambridge, MA, USA., Rothe M; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Guda S; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Parsons G; bluebird bio, Inc., Cambridge, MA, USA., Harris C; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., McGuinness M; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Abriss D; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Tsytsykova A; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Klatt D; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Bentler M; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Pellin D; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Christiansen L; bluebird bio, Inc., Cambridge, MA, USA., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Manis J; Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA., Trebeden-Negre H; Connell & O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, USA., Bonner M; bluebird bio, Inc., Cambridge, MA, USA., Esrick E; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Veres G; bluebird bio, Inc., Cambridge, MA, USA., Armant M; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Williams DA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2020 Mar 17; Vol. 17, pp. 589-600. Date of Electronic Publication: 2020 Mar 17 (Print Publication: 2020).
Autor:
Baumeister SH; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Hematology-Oncology Boston Children's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Murad J; Celdara Medical, LLC, Lebanon, New Hampshire., Werner L; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Daley H; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Trebeden-Negre H; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Gicobi JK; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Schmucker A; Celdara Medical, LLC, Lebanon, New Hampshire., Reder J; Celdara Medical, LLC, Lebanon, New Hampshire., Sentman CL; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., Gilham DE; Celyad, SA, Mont-Saint-Guibert, Belgium., Lehmann FF; Celyad, SA, Mont-Saint-Guibert, Belgium., Galinsky I; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., DiPietro H; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Cummings K; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Munshi NC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Stone RM; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Neuberg DS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Soiffer R; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Dranoff G; Novartis BioMedical Institutes, Cambridge, Massachusetts., Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Nikiforow S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts. sarah_nikiforow@dfci.harvard.edu.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2019 Jan; Vol. 7 (1), pp. 100-112. Date of Electronic Publication: 2018 Nov 05.
Autor:
Trebeden-Negre H; Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, USA., Choquet S; Department of Haematology, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière, Paris, France., Tanguy ML; Department of Statistics, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière, Paris, France., Rozenzwajg M; Biotherapy Department, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière, Paris, France., Azar N; Department of Haematology, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière, Paris, France., Lefrère F; Biotherapy Department, AP-HP, Hôpitaux Universitaires Necker Enfants Malades, Paris, France., Heshmati F; Apheresis Unit, AP-HP, Hôpitaux Universitaires Cochin, Paris, France., Belhocine R; Apheresis Unit, AP-HP, Hôpitaux Universitaires Saint Antoine, Paris, France., Vieillard V; Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Universités, UPMC University Paris 06, INSERM U1135, CNRS ERL8255, Paris, France., Norol F; Cell Therapy Unit, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière, Paris, France.
Publikováno v:
British journal of haematology [Br J Haematol] 2018 Oct; Vol. 183 (1), pp. 139-142. Date of Electronic Publication: 2017 Sep 10.
Autor:
Bhukhai K; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France., de Dreuzy E; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France., Giorgi M; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France., Colomb C; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France., Negre O; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France; bluebird bio, Inc., Cambridge, MA 02141, USA; bluebird bio France, Fontenay aux Roses 92260, France., Denaro M; bluebird bio, Inc., Cambridge, MA 02141, USA., Gillet-Legrand B; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France; bluebird bio France, Fontenay aux Roses 92260, France., Cheuzeville J; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France; bluebird bio France, Fontenay aux Roses 92260, France., Paulard A; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France; bluebird bio France, Fontenay aux Roses 92260, France., Trebeden-Negre H; Cell Therapy Unit, Pitie-Salpetriere Hospital, Paris 75013, France., Borwornpinyo S; Mahidol University, Bangkok 10400, Thailand., Sii-Felice K; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France., Maouche L; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France; INSERM, Paris 75013, France., Down JD; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Leboulch P; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France; Ramathibodi Hospital, Bangkok 10400, Thailand; Harvard Medical School and Genetics Division, Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA. Electronic address: philippe.leboulch@rics.bwh.harvard., Payen E; CEA, Institute of Biology François Jacob, Fontenay aux Roses 92260, France; UMR_007, CEA and University of Paris Saclay, Fontenay aux Roses 92260, France; INSERM, Paris 75013, France. Electronic address: emmanuel.payen@cea.fr.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2018 Feb 07; Vol. 26 (2), pp. 480-495. Date of Electronic Publication: 2017 Oct 24.
Autor:
Radhakrishnan, Vijay1 (AUTHOR) vrfgz@missouri.edu, Golla, Upendarrao2 (AUTHOR) ugolla@pennstatehealth.psu.edu, Kudva, Avinash Kundadka3,4 (AUTHOR) akk13@psu.edu
Publikováno v:
Life (2075-1729). Apr2024, Vol. 14 Issue 4, p461. 20p.
Publikováno v:
CytoJournal. 3/18/2024, Vol. 21, p1-13. 13p.